This inventor holds 1 USPTO granted patent. Top assignees: Japan Bio Products Co., Ltd., The Doshisha. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Yoshiharu Kadota: Innovator in Ocular Disease Treatment
Introduction
Yoshiharu Kadota is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of ocular diseases. His innovative approach has led to the development of a unique medicament that addresses critical health issues related to eye care.
Latest Patents
Yoshiharu Kadota holds a patent for a drug aimed at preventing and treating ocular diseases. The patent describes a medicament that includes cyclo-trans-4-L-hydroxyprolyl-L-serine as an active ingredient. This invention is particularly focused on treating dry eye conditions by enhancing mucin secretion and promoting the repair of ocular tissue damage caused by dryness. The patent showcases his commitment to improving eye health through innovative solutions.
Career Highlights
Throughout his career, Kadota has worked with reputable organizations, including Japan Bio Products Co., Ltd. and Doshisha University. His experience in these institutions has allowed him to collaborate with other professionals and contribute to advancements in medical research and product development.
Collaborations
Yoshiharu Kadota has collaborated with notable colleagues such as Takahiro Nakamura and Shumpei Yamaguchi. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.
Conclusion
Yoshiharu Kadota's work in developing a drug for ocular diseases exemplifies his dedication to medical innovation. His contributions are vital in addressing the challenges faced by individuals suffering from eye conditions. Through his patents and collaborations, he continues to make a significant impact in the field of ocular health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile